- Investing Ideas
- Taiwanese Healthcare Potentially Undervalued Small Caps
Taiwanese Healthcare Potentially Undervalued Small Caps
Results
7
Value score of at least 4 focused on companies with a low market cap.
7 companies
AViTA
Market Cap: NT$1.2b
Engages in the research, development, manufacturing, and sales of home healthcare products.
4735
NT$30.50
7D
-2.2%
1Y
-12.0%
Level Biotechnology
Market Cap: NT$1.0b
Engages in marketing and distributing cell culture, immunology, and molecular biology products in Taiwan.
3118
NT$31.75
7D
-0.2%
1Y
-1.4%
Rossmax International
Market Cap: NT$1.1b
Develops and supplies healthcare products and solutions.
4121
NT$12.90
7D
-4.4%
1Y
-12.5%
Concord Medical
Market Cap: NT$1.0b
Provides hospital management support services primarily in Taiwan.
6518
NT$31.35
7D
-0.6%
1Y
21.0%
Medical Imaging
Market Cap: NT$1.7b
Offers imaging hospital equipment leasing and maintenance services in China.
6637
NT$62.00
7D
-2.4%
1Y
-37.1%
Dynamic Medical Technologies
Market Cap: NT$2.0b
Engages in the sale, maintenance, and marketing of aesthetic lasers and light-based equipment in Taiwan and Hong Kong.
4138
NT$51.10
7D
-0.2%
1Y
-23.7%
Feng Chi Biotech
Market Cap: NT$234.1m
Engages in the wholesale and retail of medical devices and precision instruments and biotechnology services in Taiwan and internationally.
6744
NT$14.65
7D
-3.6%
1Y
-24.7%